- Home
- QNCX vs AIRG Comparison
QNCX vs AIRG Comparison
Compare QNCX & AIRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- AIRG
- Stock Information
- Founded
- QNCX 2012
- AIRG 1995
- Country
- QNCX United States
- AIRG United States
- Employees
- QNCX N/A
- AIRG N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- AIRG Radio And Television Broadcasting And Communications Equipment
- Sector
- QNCX Health Care
- AIRG Technology
- Exchange
- QNCX Nasdaq
- AIRG Nasdaq
- Market Cap
- QNCX 47.7M
- AIRG 48.7M
- IPO Year
- QNCX 2019
- AIRG 2016
- Fundamental
- Price
- QNCX $1.68
- AIRG $4.57
- Analyst Decision
- QNCX Strong Buy
- AIRG Strong Buy
- Analyst Count
- QNCX 5
- AIRG 3
- Target Price
- QNCX $8.00
- AIRG $8.50
- AVG Volume (30 Days)
- QNCX 235.8K
- AIRG 43.2K
- Earning Date
- QNCX 08-12-2025
- AIRG 08-06-2025
- Dividend Yield
- QNCX N/A
- AIRG N/A
- EPS Growth
- QNCX N/A
- AIRG N/A
- EPS
- QNCX N/A
- AIRG N/A
- Revenue
- QNCX N/A
- AIRG $58,381,000.00
- Revenue This Year
- QNCX N/A
- AIRG N/A
- Revenue Next Year
- QNCX N/A
- AIRG $23.54
- P/E Ratio
- QNCX N/A
- AIRG N/A
- Revenue Growth
- QNCX N/A
- AIRG 8.46
- 52 Week Low
- QNCX $0.51
- AIRG $3.17
- 52 Week High
- QNCX $2.45
- AIRG $10.34
- Technical
- Relative Strength Index (RSI)
- QNCX 50.83
- AIRG 51.02
- Support Level
- QNCX $1.75
- AIRG $4.71
- Resistance Level
- QNCX $2.05
- AIRG $5.15
- Average True Range (ATR)
- QNCX 0.16
- AIRG 0.45
- MACD
- QNCX -0.02
- AIRG 0.01
- Stochastic Oscillator
- QNCX 9.76
- AIRG 23.81
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About AIRG Airgain Inc.
Airgain Inc is engaged in providing antenna technologies. These technologies can be used to enable performance wireless networking across devices and markets which include connected homes, enterprises, automotive, and the Internet of Things. It also provides solutions to complex radio frequency, engineering challenges, and improving wireless service that require higher throughput, broad coverage footprint, and carrier-grade quality. Geographically, it derives maximum revenue from North America and also has a presence in China and the Rest of the World. The company products include Antenna Plus: Fleet, M2M, IoT Antennas, Carrier-Class Antenna, Embedded Antennas, and External Dipole Antennas.